FSH glycosylation mutant

Details for Australian Patent Application No. 2004268683 (hide)

Owner Merck Serono SA

Inventors McKenna, Sean D.; Brondyk, William H.; Garone, Louise M.; Tepper, Mark; Jiang, Xuliang; Arkinstall, Stephen J.; Campbell, Robert K.

Agent Griffith Hack

Pub. Number AU-B-2004268683

PCT Pub. Number WO2005/020934

Priority 60/499,802 02.09.03 US

Filing date 2 September 2004

Wipo publication date 10 March 2005

Acceptance publication date 24 June 2010

International Classifications

C07K 14/59 (2006.01) Peptides having more than 20 amino acids

Event Publications

9 March 2006 PCT application entered the National Phase

  PCT publication WO2005/020934 Priority application(s): WO2005/020934

13 July 2006 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 24 May 2006

25 October 2007 Assignment before Grant

  Applied Research Systems ARS Holding N.V The application has been assigned to Laboratoires Serono SA

23 April 2009 Alteration of Name

  The name of the applicant has been altered to Merck Serono SA

24 June 2010 Application Accepted

  Published as AU-B-2004268683

21 October 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004268687-A watercraft carrier

2004268679-Formulation of a mixture of Free-B-Ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments